Alcon Inc logo

Alcon Inc

NEW
NYSE:ALC (Switzerland)  
$ 67.93 +1.81 (+2.74%) 07:09 PM EST
40.92
P/B:
1.53
Market Cap:
$ 33.39B
Enterprise V:
$ 36.60B
Volume:
1.56M
Avg Vol (2M):
2.28M
Trade In:
Volume:
1.56M
Avg Vol (2M):
2.28M

Business Description

Description
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Alcon Inc Filings

Filing Date Document Date Form
No Filing Data

Alcon Inc Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings conference call for 2026 2026-11-11 In 139 days
Third quarter earnings results for 2026 2026-11-11 In 139 days
Second quarter earnings conference call for 2026 2026-08-11 In 47 days
Second quarter earnings results for 2026 2026-08-11 In 47 days
First quarter earnings conference call for 2026 2026-05-06 08:00 74.45 (+0.54%)
CHF 0.280000 Cash Dividend 2026-05-06 74.45 (+0.54%)
First quarter earnings results for 2026 2026-05-06 74.45 (+0.54%)
General meeting for 2026 2026-04-30 72.81 (-2.01%)
Fourth quarter earnings conference call for 2025 2026-02-25 08:00 84.13 (-0.27%)
Fourth quarter earnings results for 2025 2026-02-25 84.13 (-0.27%)
Show
Entries

Guru Commentaries on NYSE:ALC

No articles.

Articles on Alcon Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1